Related Experiment Video
Updated: May 30, 2026
12:27
The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 2, 2014
Differences in local and systemic inflammatory markers in patients with obstructive airways disease
Lisa Tilemann1, Lena Gindner, Franz Meyer
1Technische Universität München, Klinikum rechts der Isar, Institute of General Practice, Munich, Germany. talysat@gmx.de
Summary
Inflammatory markers like hs-CRP, IgE, eosinophils, and fractional exhaled nitric oxide (FE(NO)) help distinguish between asthma and COPD. These markers aid in diagnosing obstructive airways disease in primary care settings.
Area of Science:
- Pulmonary Medicine
- Clinical Immunology
- Respiratory Inflammation
Background:
- Asthma and COPD involve airway and systemic inflammation, but distinct inflammatory marker profiles are not well-defined.
- Understanding these differences is crucial for accurate diagnosis and management of obstructive airways diseases.
Purpose of the Study:
- To investigate and compare inflammatory markers in patients with obstructive airways disease.
- To determine the utility of specific markers in differentiating between asthma and COPD.
Main Methods:
- Assessed lung function, fractional exhaled nitric oxide (FE(NO)), blood eosinophils, serum IgE, and high-sensitivity C-reactive protein (hs-CRP) in 210 adult patients.
- Utilized Receiver Operating Characteristic (ROC) analysis to evaluate diagnostic accuracy.
Main Results:
- COPD patients showed elevated hs-CRP, while asthma patients had increased FE(NO), IgE, and eosinophils.
- hs-CRP demonstrated the highest area under the curve (AUC=0.651) for COPD diagnosis, and FE(NO) for asthma diagnosis (AUC=0.618).
- hs-CRP correlated with smoking pack-years and inversely with lung function.
Conclusions:
- Serum hs-CRP, IgE, blood eosinophils, and FE(NO) reflect distinct local and systemic inflammation patterns in obstructive airways disease.
- These markers can assist in differentiating asthma from COPD in primary care, especially when spirometry is unavailable.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...